betoptic s 25 mg ml eye drops suspension - search results

betoptic s 2.5mg/ml, eye drops, suspension

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - betaxolol hydrochloride - eye drops, suspension - betaxolol hydrochloride 2.5 mg/ml - ophthalmologicals

Malta - English - Medicines Authority

betoptic s 2.5mg/ml, eye drops, suspension

s.a alcon-couvreur n.v. - betaxolol hydrochloride 2.5 mg/ml - eye drops, suspension

Australia - English - Department of Health (Therapeutic Goods Administration)

betoptic betaxolol 5mg/ml (as hydrochloride) eye drops bottle

novartis pharmaceuticals australia pty ltd - betaxolol hydrochloride, quantity: 5.6 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; sodium hydroxide; sodium chloride; hydrochloric acid; disodium edetate; purified water - indications as at 23 march 1999: betoptic 0.5% have been shown to be effective in lowering intraocular pressure and are indicated in the treatment of ocular hypertension or chronic open angular glaucoma. betoptic eye drops 0.5% may be used alone or in combination with other iop-lowering medication.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betoptic 0.25% eye drops suspension 0.25ml unit dose

immedica pharma ab - betaxolol hydrochloride - eye drops - 2.5mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

betoquin betaxolol 5.0mg/ml (as hydrochloride) eye drops solution bottle

novartis pharmaceuticals australia pty ltd - betaxolol hydrochloride, quantity: 5.6 mg/ml (equivalent: betaxolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: purified water; disodium edetate; sodium chloride; hydrochloric acid; benzalkonium chloride; sodium hydroxide - indications as at 23 march 1999: betoquin eye drops 0.5% have been shown to be effective in lowering intraocular pressure and are indicated in the treatment of ocular hypertension or chronic open angular glaucoma. betoquin eye drops 0.5% may be used alone or in combination with other iop-lowering medication.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)